European Companies Search Engine
UK funding (£601,387): Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR) Ukri 1 Nov 2008 UK Research and Innovation, United Kingdom
Overview
Text
Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR)
| Abstract | Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details. |
| Category | Collaborative R&D |
| Reference | 100569 |
| Status | Closed |
| Funded period start | 01/11/2008 |
| Funded period end | 31/10/2010 |
| Funded value | £601,387.00 |
| Source | https://gtr.ukri.org/projects?ref=100569 |
Participating Organisations
| DNAE GROUP HOLDINGS LIMITED |
£286,010.00 |
| IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE |
£271,035.00 |
| PFIZER LIMITED |
£44,342.00 |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Dnae Group Holdings Ltd., London.